↓ Skip to main content

Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19

Overview of attention for article published in Thrombosis Journal, August 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19
Published in
Thrombosis Journal, August 2021
DOI 10.1186/s12959-021-00308-4
Pubmed ID
Authors

Fumihiro Ogawa, Yasufumi Oi, Kento Nakajima, Reo Matsumura, Tomoki Nakagawa, Takao Miyagawa, Kazuya Sakai, Ryo Saji, Hayato Taniguchi, Kohei Takahashi, Takeru Abe, Masayuki Iwashita, Mototsugu Nishii, Ichiro Takeuchi

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 11%
Other 2 7%
Student > Bachelor 2 7%
Student > Master 2 7%
Student > Ph. D. Student 2 7%
Other 4 15%
Unknown 12 44%
Readers by discipline Count As %
Medicine and Dentistry 6 22%
Biochemistry, Genetics and Molecular Biology 2 7%
Social Sciences 2 7%
Economics, Econometrics and Finance 2 7%
Environmental Science 1 4%
Other 2 7%
Unknown 12 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 October 2021.
All research outputs
#14,555,398
of 23,310,485 outputs
Outputs from Thrombosis Journal
#186
of 337 outputs
Outputs of similar age
#199,545
of 400,551 outputs
Outputs of similar age from Thrombosis Journal
#9
of 12 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 337 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 400,551 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.